NCT01771328.

Trial name or title	Continuous Subcutaneous Hydrocortisone Infusion in Congenital Adrenal Hyperplasia (CAH)
Methods	Open‐label, Phase 2 RCT. Cross‐over design. Location: Haukeland University Hospital. Duration: 4 months (Arm 1) and 6 months (Arm 2).
Participants	20 participants. Age: 18 ‐ 60 years. Gender: both females and males eligible. Diagnosis: classical CAH due to 21‐hydroxylase deficiency.
Interventions	Arm 1: HC 10 mg/m²/24 hours subcutaneous infusion. Arm 2: cortisone acetate tablets.
Outcomes	Primary: 17 OHP, ACTH, cortisol, bone markers, testosterone, androstenedione. Secondary: body weight, blood pressure.
Starting date	February 2013.
Contact information	Kristian Løvås, MD, PhD.
Notes